News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
242,732 Results
Type
Article (7804)
Company Profile (54)
Press Release (234872)
Multimedia
Podcasts (6)
Webinars (2)
Section
Business (72541)
Career Advice (231)
Deals (15798)
Drug Delivery (14)
Drug Development (31014)
Employer Resources (13)
FDA (5207)
Job Trends (5463)
News (123375)
Policy (10721)
Tag
2027 Pharm Country Standard (1)
Academia (809)
Accelerated approval (20)
Adcomms (1)
Allergies (52)
Alliances (12312)
ALS (65)
Alzheimer's disease (668)
Antibody-drug conjugate (ADC) (149)
Approvals (5521)
Artificial intelligence (143)
Autoimmune disease (85)
Automation (16)
Bankruptcy (120)
Best Places to Work (4984)
BIOSECURE Act (3)
Biosimilars (29)
Biotechnology (33)
Bladder cancer (72)
Brain cancer (25)
Breast cancer (291)
Cancer (2176)
Cardiovascular disease (166)
Career advice (209)
Career pathing (4)
CAR-T (109)
CDC (4)
Celiac Disease (1)
Cell therapy (263)
Cervical cancer (16)
Clinical research (27832)
Collaboration (474)
Company closure (2)
Compensation (321)
Complete response letters (18)
COVID-19 (1203)
CRISPR (31)
C-suite (206)
Cystic fibrosis (52)
Data (3381)
Decentralized trials (1)
Denatured (1)
Depression (82)
Dermatology (36)
Diabetes (191)
Diagnostics (2550)
Digital health (18)
Diversity, equity & inclusion (1)
Drug discovery (64)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (84)
Earnings (48330)
Editorial (11)
Employer branding (3)
Employer resources (13)
Events (40905)
Executive appointments (207)
FDA (6710)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (8)
Frontotemporal dementia (14)
Funding (341)
Gene editing (61)
Generative AI (4)
Gene therapy (152)
GLP-1 (287)
Government (1629)
Grass and pollen (3)
Guidances (338)
Healthcare (7563)
HIV (30)
Huntington's disease (15)
IgA nephropathy (30)
Immunology and inflammation (75)
Immuno-oncology (23)
Indications (77)
Infectious disease (1318)
Inflammatory bowel disease (84)
Influenza (47)
Intellectual property (96)
Interviews (38)
IPO (10426)
IRA (3)
Job creations (678)
Job search strategy (179)
JPM (9)
Kidney cancer (7)
Labor market (22)
Layoffs (109)
Leadership (5)
Legal (2074)
Liver cancer (37)
Longevity (14)
Lung cancer (300)
Lymphoma (182)
Machine learning (14)
Management (5)
Manufacturing (204)
MASH (88)
Medical device (5599)
Medtech (5626)
Mergers & acquisitions (5838)
Metabolic disorders (465)
mRNA (35)
Multiple sclerosis (60)
NASH (10)
Neurodegenerative disease (145)
Neuropsychiatric disorders (30)
Neuroscience (1153)
NextGen: Class of 2026 (1715)
Non-profit (1369)
Now hiring (8)
Obesity (174)
Opinion (24)
Ovarian cancer (96)
Pain (73)
Pancreatic cancer (119)
Parkinson's disease (102)
Partnered (8)
Patents (176)
Patient recruitment (162)
Peanut (23)
People (14605)
Pharmaceutical (12)
Pharmacy benefit managers (3)
Phase 1 (7862)
Phase 2 (12152)
Phase 3 (10370)
Pipeline (4105)
Policy (26)
Postmarket research (889)
Preclinical (2922)
Press Release (15)
Prostate cancer (100)
Psychedelics (7)
Radiopharmaceuticals (132)
Rare diseases (322)
Real estate (1251)
Recruiting (7)
Regulatory (8797)
Reports (11)
Research institute (655)
Resumes & cover letters (23)
Rett syndrome (12)
RNA editing (4)
RSV (35)
Schizophrenia (79)
Series A (54)
Series B (41)
Service/supplier (6)
Sickle cell disease (36)
Special edition (10)
Spinal muscular atrophy (84)
Sponsored (7)
Startups (672)
State (1)
Stomach cancer (1)
Supply chain (32)
Tariffs (12)
The Weekly (5)
Vaccines (297)
Venture capital (19)
Weight loss (93)
Women's health (27)
Worklife (2)
Date
Today (141)
Last 7 days (420)
Last 30 days (1242)
Last 365 days (11155)
2026 (4007)
2025 (11239)
2024 (13243)
2023 (15223)
2022 (18850)
2021 (20145)
2020 (41846)
2019 (15553)
2018 (10707)
2017 (10568)
2016 (8599)
2015 (11218)
2014 (7529)
2013 (5238)
2012 (6057)
2011 (6579)
2010 (5737)
Location
Africa (152)
Alabama (37)
Alaska (1)
Arizona (100)
Arkansas (1)
Asia (14647)
Australia (2149)
California (5040)
Canada (1082)
China (455)
Colorado (247)
Connecticut (260)
Delaware (198)
Europe (30269)
Florida (760)
Georgia (126)
Idaho (11)
Illinois (377)
India (15)
Indiana (269)
Iowa (4)
Japan (191)
Kansas (76)
Kentucky (11)
Louisiana (25)
Maine (33)
Maryland (553)
Massachusetts (3194)
Michigan (110)
Minnesota (239)
Mississippi (1)
Missouri (74)
Montana (8)
Nebraska (6)
Nevada (31)
New Hampshire (26)
New Jersey (1631)
New Mexico (6)
New York (1353)
North Carolina (473)
North Dakota (5)
Northern California (2548)
Ohio (121)
Oklahoma (2)
Oregon (6)
Pennsylvania (1086)
Puerto Rico (2)
Rhode Island (5)
South America (273)
South Carolina (14)
Southern California (2042)
Tennessee (38)
Texas (820)
United States (17464)
Utah (136)
Virginia (129)
Washington D.C. (7)
Washington State (353)
West Virginia (1)
Wisconsin (26)
242,732 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enpro to Present at Oppenheimer 21st Annual Industrial Growth Conference
April 30, 2026
·
1 min read
Press Releases
Innate Pharma to Hold Its Annual General Meeting of Shareholders on May 21, 2026
April 13, 2026
·
3 min read
Deals
Lilly can’t stop the dealing, with nearly $21B spent on M&A this year—so far
With six acquisitions already this year, Eli Lilly’s business development shows no signs of stopping as executives make good on a promise to spend their GLP-1 gains.
April 29, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
March 30, 2026
·
1 min read
Mergers & acquisitions
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
Following last month’s $7.8 billion purchase of CAR T biotech Arcellx, Gilead’s dealmaking train chugs along with yet another acquisition—this time securing Ouro Medicines’ pipeline of T cell engagers for inflammatory diseases.
March 24, 2026
·
3 min read
·
Tristan Manalac
Press Releases
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
March 19, 2026
·
1 min read
Press Releases
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - April 21, 2026
April 22, 2026
·
1 min read
Weight loss
Novo Leans Into Oral Route With Weight Loss Partnership Worth up to $2.1B
After its next-generation obesity asset CagriSema lost a head-to-head matchup with Eli Lilly’s Zepbound, Novo Nordisk is throwing more money into the obesity space, striking a deal with Vivtex to advance novel weight loss pills.
February 25, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
April 28, 2026
·
9 min read
Press Releases
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition
April 20, 2026
·
8 min read
1 of 24,274
Next
